» Articles » PMID: 30577897

"No More Falling Through the Cracks": A Qualitative Study to Inform Measurement of Integration of Care of HIV and Opioid Use Disorder

Overview
Specialty Psychiatry
Date 2018 Dec 23
PMID 30577897
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Integration of HIV- and opioid use disorder (OUD)-related care is associated with improved patient outcomes. Our goal was to develop a novel instrument for measuring quality of integration of HIV and OUD-related care that would be applicable across diverse care settings.

Methods: Grounded in community-based participatory research principles, we conducted a qualitative study from August through November 2017 to inform modification of the Behavioral Health Integration in Medical Care (BHIMC) instrument, a validated measure of quality of integration of behavioral health in primary care. We conducted semi-structured interviews of patients (n = 22), focus groups with clinical staff (n = 24), and semi-structured interviews of clinic leadership (n = 5) in two urban centers in Connecticut.

Results: We identified three themes that characterize optimal integration of HIV- and OUD-related care: (1) importance of mitigating mismatches in resources and knowledge, particularly resources to address social risks and knowledge gaps about evidence-based treatments for OUD; (2) need for patient-centered policies and inter-organization communication, and (3) importance of meeting people where they are, geographically and at their stage of change. These themes highlighted aspects of integrated care for HIV and OUD not captured in the original BHIMC.

Conclusions: Patients, clinical staff, and organization leadership perceive that addressing social risks, communication across agencies, and meeting patients in their psychosocial and structural context are important for optimizing integration of HIV and OUD-related care. Our proposed, novel instrument is a step towards measuring and improving service delivery locally and nationally for this vulnerable population.

Citing Articles

Considerations when prescribing opioid agonist therapies for people living with HIV.

Tarfa A, Lier A, Shenoi S, Springer S Expert Rev Clin Pharmacol. 2024; 17(7):549-564.

PMID: 38946101 PMC: 11299801. DOI: 10.1080/17512433.2024.2375448.


Perspectives on unhealthy alcohol use among men who have sex with men prescribed HIV pre-exposure prophylaxis: A qualitative study.

Strong S, Oldfield B, Berg J, Cole C, Biegacki E, Ogbuagu O Prev Med Rep. 2024; 37:102553.

PMID: 38282665 PMC: 10810836. DOI: 10.1016/j.pmedr.2023.102553.


Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial.

Muvvala S, Gan G, Morford K, Dziura J, Esserman D, Porter E J Addict Med. 2023; 17(6):e388-e391.

PMID: 37934538 PMC: 10726383. DOI: 10.1097/ADM.0000000000001192.


Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol.

Langdon K, Hitch A, Collins A, Beckwith C, Becker S, Tashima K Addict Sci Clin Pract. 2023; 18(1):60.

PMID: 37838707 PMC: 10576282. DOI: 10.1186/s13722-023-00418-6.


Patients' perspectives of medications for addiction treatment in HIV clinics: A qualitative study.

Morford K, Muvvala S, Chan P, Cornman D, Doernberg M, Porter E J Subst Abuse Treat. 2022; 139:108767.

PMID: 35341613 PMC: 9187601. DOI: 10.1016/j.jsat.2022.108767.